Skip to main content
What types of page to search?

Alternatively use our A-Z index.

Publications

What type of publication do you want to show?

2024

2023

Deep Immune Profiling Identifies Novel T-Cell Subpopulations That Influence Specific Clinical Outcomes in Chronic Lymphocytic Leukaemia (CLL)

Lim, Y. J., Duckworth, A., Clarke, K., Kennedy, P., Oates, M., Gornall, M., . . . Pettitt, A. (2023). Deep Immune Profiling Identifies Novel T-Cell Subpopulations That Influence Specific Clinical Outcomes in Chronic Lymphocytic Leukaemia (CLL). Blood, 142(Supplement 1), 4626. doi:10.1182/blood-2023-185091

DOI
10.1182/blood-2023-185091
Journal article

High Dimensional Detection of Non-Malignant B-Cells and Its Clinical Implications in Patients with Chronic Lymphocytic Leukaemia (CLL) Undergoing Frontline Therapy

Lim, Y. J., Duckworth, A., Clarke, K., Oates, M., Gornall, M., Kalakonda, N., . . . Pettitt, A. (2023). High Dimensional Detection of Non-Malignant B-Cells and Its Clinical Implications in Patients with Chronic Lymphocytic Leukaemia (CLL) Undergoing Frontline Therapy. Blood, 142(Supplement 1), 1894. doi:10.1182/blood-2023-185018

DOI
10.1182/blood-2023-185018
Journal article

Immunomodulatory Effects of Chemo-Immunotherapy ± Idelalisib in Chronic Lymphocytic Leukaemia (CLL)

Lim, Y. J., Duckworth, A., Clarke, K., Oates, M., Gornall, M., Kalakonda, N., . . . Pettitt, A. (2023). Immunomodulatory Effects of Chemo-Immunotherapy ± Idelalisib in Chronic Lymphocytic Leukaemia (CLL). Blood, 142(Supplement 1), 1455. doi:10.1182/blood-2023-185063

DOI
10.1182/blood-2023-185063
Journal article

P1095: COVID-19 VACCINE RESPONSES IN FOLLICULAR LYMPHOMA: DETERMINANTS OF HUMORAL AND CELLULAR IMMUNITY IN THE PETREA TRIAL OF FRONTLINE CHEMOIMMUNOTHERAPY

Jer Lim, Y., Ward, V., Farrell, L., Naisbitt, D., Brown, A., Phillips, E., . . . Pettitt, A. (n.d.). P1095: COVID-19 VACCINE RESPONSES IN FOLLICULAR LYMPHOMA: DETERMINANTS OF HUMORAL AND CELLULAR IMMUNITY IN THE PETREA TRIAL OF FRONTLINE CHEMOIMMUNOTHERAPY. HemaSphere, 7(S3), e49729ac. doi:10.1097/01.hs9.0000971276.49729.ac

DOI
10.1097/01.hs9.0000971276.49729.ac
Journal article

2022

2021

Autologous Hematopoietic Stem Cell Transplantation for Behcet's Disease: A Retrospective Survey of Patients Treated in Europe, on Behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation

Puyade, M., Patel, A., Lim, Y. J., Blank, N., Badoglio, M., Gualandi, F., . . . Snowden, J. A. (2021). Autologous Hematopoietic Stem Cell Transplantation for Behcet's Disease: A Retrospective Survey of Patients Treated in Europe, on Behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation. In FRONTIERS IN IMMUNOLOGY Vol. 12. doi:10.3389/fimmu.2021.638709

DOI
10.3389/fimmu.2021.638709
Conference Paper

2020

Outcomes of older patients with primary central nervous system lymphoma treated in routine clinical practice in the UK: methotrexate dose intensity correlates with response and survival

Martinez-Calle, N., Poynton, E., Alchawaf, A., Kassam, S., Horan, M., Rafferty, M., . . . Cwynarski, K. (2020). Outcomes of older patients with primary central nervous system lymphoma treated in routine clinical practice in the UK: methotrexate dose intensity correlates with response and survival. BRITISH JOURNAL OF HAEMATOLOGY, 190(3), 394-404. doi:10.1111/bjh.16592

DOI
10.1111/bjh.16592
Journal article

2019

Real-World Outcomes of Older Patients with Primary Central Nervous System Lymphoma (PCNSL): Methotrexate Dose Intensity and Combination with Cytarabine Correlate with Response and Survival

Poynton, E., Martinez-Calle, N., Alchawaf, A., Kassam, S., Horan, M., Rafferty, M., . . . Fox, C. (2019). Real-World Outcomes of Older Patients with Primary Central Nervous System Lymphoma (PCNSL): Methotrexate Dose Intensity and Combination with Cytarabine Correlate with Response and Survival. In BRITISH JOURNAL OF HAEMATOLOGY Vol. 185 (pp. 28-29). Retrieved from https://www.webofscience.com/

Conference Paper

2018

Long-Term Safety and Efficacy of Autologous or Allogeneic Donor Stem Cell Transplantation in Patients with Behcet's Syndrome

Patel, A., & Lim, Y. J. (2018). Long-Term Safety and Efficacy of Autologous or Allogeneic Donor Stem Cell Transplantation in Patients with Behcet's Syndrome. In BLOOD Vol. 132. doi:10.1182/blood-2018-99-115815

DOI
10.1182/blood-2018-99-115815
Conference Paper

Randomized Trials of Autologous Hematopoietic Stem Cell Transplantation for Diffuse Cutaneous Systemic Sclerosis: Systematic Review and Meta-Analysis with Trial Sequential Analysis of Overall Mortality

Patel, A., & Lim, Y. J. (2018). Randomized Trials of Autologous Hematopoietic Stem Cell Transplantation for Diffuse Cutaneous Systemic Sclerosis: Systematic Review and Meta-Analysis with Trial Sequential Analysis of Overall Mortality. In BLOOD Vol. 132. doi:10.1182/blood-2018-99-115326

DOI
10.1182/blood-2018-99-115326
Conference Paper

Real-World Outcomes of Older Patients with Primary Central Nervous System Lymphoma (PCNSL): Methotrexate Dose Intensity and Combination with Cytarabine Correlate with Response and Survival

Martinez-Calle, N., Poynton, E., Alchawaf, A., Kassam, S., Horan, M., Rafferty, M., . . . Cwynarski, K. (2018). Real-World Outcomes of Older Patients with Primary Central Nervous System Lymphoma (PCNSL): Methotrexate Dose Intensity and Combination with Cytarabine Correlate with Response and Survival. In BLOOD Vol. 132. doi:10.1182/blood-2018-99-111901

DOI
10.1182/blood-2018-99-111901
Conference Paper

Ruxolitinib in Myelofibrosis: a multicentre experience in England, Northern Ireland and Wales

Russell, J., Daly, A., Fisken, R., Dicu, A., Cunningham, J., Sparksman, D., . . . Sadullah, S. (2018). Ruxolitinib in Myelofibrosis: a multicentre experience in England, Northern Ireland and Wales. In BRITISH JOURNAL OF HAEMATOLOGY Vol. 181 (pp. 10). Retrieved from https://www.webofscience.com/

Conference Paper

Utility of 18F-FDG PET/CT in the diagnosis and assessment of myeloma associated bone disease: a single centre experience

Lim, Y. J., Taheri, A., Fernando, R., Seshadri, N., Brearton, G., & Hawkins, S. (2018). Utility of 18F-FDG PET/CT in the diagnosis and assessment of myeloma associated bone disease: a single centre experience. In BRITISH JOURNAL OF HAEMATOLOGY Vol. 181 (pp. 105-106). Retrieved from https://www.webofscience.com/

Conference Paper

2017

Treatment of newly diagnosed central nervous system (<scp>CNS</scp>) lymphoma patients based on co‐morbidities &amp; performance status: A single‐centre experience

Lim, Y., & Smith, J. (2017). Treatment of newly diagnosed central nervous system (<scp>CNS</scp>) lymphoma patients based on co‐morbidities &amp; performance status: A single‐centre experience. Hematological Oncology, 35(S2), 352-353. doi:10.1002/hon.2439_104

DOI
10.1002/hon.2439_104
Journal article

TREATMENT OF NEWLY DIAGNOSED CENTRAL NERVOUS SYSTEM LYMPHOMA PATIENTS BASED ON COMORBIDITIES & PERFORMANCE STATUS: A SINGLE-CENTRE EXPERIENCE

Lim, Y. J., & Smith, J. (2017). TREATMENT OF NEWLY DIAGNOSED CENTRAL NERVOUS SYSTEM LYMPHOMA PATIENTS BASED ON COMORBIDITIES & PERFORMANCE STATUS: A SINGLE-CENTRE EXPERIENCE. In HAEMATOLOGICA Vol. 102 (pp. 699). Retrieved from https://www.webofscience.com/

Conference Paper